➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Merck
Colorcon
Baxter
McKinsey

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TESTIM

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Testim

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00156650 ↗ Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 1/Phase 2 2004-12-01 This study is being offered to all participants of the ACY-5 study as an optional addition to the male contraceptive study in which they participated. Participation is voluntary. The purpose of this added procedure (Testicular Aspiration-HOP 3) is to determine the amount of testosterone (male hormone) in the testes of men who are on a male contraceptive regimen.
NCT00156650 ↗ Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum Completed University of Washington Phase 1/Phase 2 2004-12-01 This study is being offered to all participants of the ACY-5 study as an optional addition to the male contraceptive study in which they participated. Participation is voluntary. The purpose of this added procedure (Testicular Aspiration-HOP 3) is to determine the amount of testosterone (male hormone) in the testes of men who are on a male contraceptive regimen.
NCT00161447 ↗ Male Hormonal Contraceptive Development-ACY-5 Completed CONRAD Phase 1/Phase 2 2004-05-01 The purpose of this research study is to help in the development of male contraception (birth control).
NCT00161447 ↗ Male Hormonal Contraceptive Development-ACY-5 Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 1/Phase 2 2004-05-01 The purpose of this research study is to help in the development of male contraception (birth control).
NCT00161447 ↗ Male Hormonal Contraceptive Development-ACY-5 Completed University of Washington Phase 1/Phase 2 2004-05-01 The purpose of this research study is to help in the development of male contraception (birth control).
NCT00161486 ↗ The Effects of Testosterone on Prostate Tissue (ACYP-1) Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 1 2004-07-01 The purpose of this research study is to understand the effects of testosterone on the prostate. This knowledge will be used to help in the development of a safe male hormonal contraceptive and may impact the development of androgen replacement therapy in older men.
NCT00161486 ↗ The Effects of Testosterone on Prostate Tissue (ACYP-1) Completed University of Washington Phase 1 2004-07-01 The purpose of this research study is to understand the effects of testosterone on the prostate. This knowledge will be used to help in the development of a safe male hormonal contraceptive and may impact the development of androgen replacement therapy in older men.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Testim

Condition Name

Condition Name for Testim
Intervention Trials
Hypogonadism 7
Contraception 4
Secondary Hypogonadism 2
Hypogonadotropic Hypogonadism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Testim
Intervention Trials
Hypogonadism 9
Neoplasm Metastasis 2
Metabolic Syndrome X 1
Prostatic Hyperplasia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Testim

Trials by Country

Trials by Country for Testim
Location Trials
United States 18
Denmark 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Testim
Location Trials
Washington 7
Texas 4
California 3
Nevada 2
New York 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Testim

Clinical Trial Phase

Clinical Trial Phase for Testim
Clinical Trial Phase Trials
Phase 4 3
Phase 2/Phase 3 1
Phase 2 4
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Testim
Clinical Trial Phase Trials
Completed 10
Terminated 2
Recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Testim

Sponsor Name

Sponsor Name for Testim
Sponsor Trials
University of Washington 7
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 6
Repros Therapeutics Inc. 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Testim
Sponsor Trials
Other 11
Industry 7
NIH 6
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Harvard Business School
Johnson and Johnson
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.